| Year | Sales (Billion USD PPP) | Year-on-Year Variation (%) |
|---|---|---|
| 2024 | 1.68 | N/A |
| 2025 | 1.73 | 2.98% |
| 2026 | 1.76 | 1.73% |
| 2027 | 1.79 | 1.70% |
| 2028 | 1.81 | 1.12% |
CAGR (2024-2028): 1.71%
Future trends to watch include advancements in biotechnology, increased awareness of cardiovascular health, and regulatory changes that could impact market dynamics. Additionally, the aging population in Spain may contribute to sustained demand for renin-angiotensin system medications.
